Home > Treatment Recommendations > Neonates/Paediatric Patients > Respiratory > Pneumonia, Hospital-acquired (HAP) > Late onset, prior broad spectrum antibiotics, structural lung disease, immunosuppression > S. aureus/MRSA

Linezolid preferred over vancomycin if:

  • MRSA with vancomycin MIC ≥ 1.5µg/mL
  • concomitant nephrotoxic therapy
  • pre-existing renal dysfunction.
Content Version: 1.1.1151 Oct 31, 2024.06:09
©1998-2020 Alberta Health Services